Biocartis is latest European life sciences IPO hopeful
This article was originally published in Scrip
Executive Summary
The molecular diagnostics technology specialist Biocartis, headed by seasoned Belgian biotech entrepreneur Rudi Pauwels, has announced plans to raise funds through an initial public offering list on Euronext Brussels. The firm launched its first commercial product, Idylla, in September 2014.